gastrin-17 and Neoplasms

gastrin-17 has been researched along with Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for gastrin-17 and Neoplasms

ArticleYear
Expression, purification and characterization of recombinant toxins consisting of truncated gastrin 17 and pseudomonas exotoxin.
    Protein and peptide letters, 2015, Volume: 22, Issue:2

    Gastric cancer is a major cause of mortality and morbidity around world. However the effectiveness of the current approaches to the diagnosis and treatment of gastric cancer is limited. Recombinant targeted toxins may represent a novel direction of cancer therapy. In this study, we aimed to explore whether recombinant toxins fused with the truncated forms of G17 could target to kill cancer cells by recognizing CCK2R. Four recombinant Pseudomonas toxins PE38 fused with the forward or reverse truncated forms of G17 (G14 and G13) were successfully constructed, expressed, and purified. Their characteristics were further analyzed by SDS-PAGE, western blot and indirect immunofluorescence assay. The cytotoxicity assay demonstrated that only reversely fused recombinant toxins rG14PE38 and rG13PE38 exhibited certain toxicity on several cancer cell lines, and a competition assay indicated that the binding of the reverse gastrin-endotoxin to CCK2R (+) cells may be mediated by interaction between gastrin/gastrin-like and CCK2R.

    Topics: Blotting, Western; Cell Survival; DNA Primers; Electrophoresis, Polyacrylamide Gel; Exotoxins; Fluorescent Antibody Technique, Indirect; Gastrins; Humans; Neoplasms; Polymerase Chain Reaction; Pseudomonas; Receptor, Cholecystokinin B; Recombinant Proteins; Toxins, Biological; Tumor Cells, Cultured

2015
Binding of gastrin(17) to human gastric carcinoma cell lines.
    Cancer research, 1988, Feb-15, Volume: 48, Issue:4

    The hormone gastrin stimulates acid secretion by gastric parietal cells and acts as a growth factor for the gastric mucosa. Gastrin receptors with dissociation constants of approximately 0.5 nM have been detected on isolated gastric parietal cells, and on some cell lines derived from colon carcinomas. We now report that gastrin is also bound by five cell lines derived from human gastric carcinomas, but that the affinities of these lines for gastrin range from 0.2 to 1.3 microM. Cholecystokinin8 binds to the cell line Okajima with an affinity similar to gastrin17, while shorter gastrin analogues bind with reduced affinity. Binding of gastrin is unaffected by acetylcholine, histamine, or a number of other hormones with the exception of insulin which inhibits binding with an IC50 value of 0.5 microM. The ability to bind gastrin with affinities in the microM range appears to be a property widespread among other tumor cell lines.

    Topics: Animals; Binding, Competitive; Cell Line; Dogs; Gastrins; Hormones; Humans; Kinetics; Neoplasms; Parietal Cells, Gastric; Receptors, Cholecystokinin; Stomach Neoplasms

1988